Li-Fraumeni syndrome: cancer risk assessment and clinical managementKate A. McBride, Gillian Mitchell, Mandy L. Ballinger et al.|Nature Reviews Clinical Oncology|2014Cited by 276
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Rosalind A. Eeles, Elizabeth Bancroft et al.|Familial Cancer|2017Cited by 68